Stay updated with breaking news from Subversive Acquisition. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Leading global cannabis companies InterCure and Clever Leaves partner together to cultivate, market, and distribute pharmaceutical-grade medical cannabis in the EU, Australia and IsraelNEW YORK and... | March 22, 2022
Press release content from Globe Newswire. The AP news staff was not involved in its creation.
Estimated revenue reaches over CAD$31 million Anticipates continued increases in adjusted operating profit and EBITDA Revenue growth expected to continue throughout 2022 TORONTO and... | February 8, 2022
Achieved a number of firsts and records including: Seventh consecutive quarter of double-digit revenue growth Seventh consecutive quarter of high digit...
solid demand TORONTO and HERZLIYA, Israel, May 20, 2021 (GLOBE NEWSWIRE) — InterCure Ltd. (TSX: INCR:U, TASE: INCR)(dba Canndoc)(“InterCure” or the “Company”) today announced that it signed a definitive agreement to acquire a licensed active medical cannabis trading house and two pharmacies. The trading house is approved by the Israeli Medical Cannabis Agency (IMCA) and is one of the leading operating trading houses in the country, authorized to distributing GMP medical cannabis products to pharmacies. As part of GMP regulations, medical cannabis products can dispense through IMCA ...